{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:14:28Z","timestamp":1774620868595,"version":"3.50.1"},"reference-count":208,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2025\/R\/1446"],"award-info":[{"award-number":["PSAU\/2025\/R\/1446"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.neuroscience.2025.03.064","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T08:35:14Z","timestamp":1743410114000},"page":"167-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A review: From old drugs to new solutions: The role of repositioning in alzheimer\u2019s disease treatment"],"prefix":"10.1016","volume":"576","author":[{"given":"Fawad Ali","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halima","family":"Qadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehan Zeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2025.03.064_b0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nbt0712-571a","article-title":"NCATS launches drug repurposing program","volume":"30","author":"Allison","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1517\/14656566.2013.791677","article-title":"Evaluation of everolimus in renal cell cancer","volume":"14","author":"Amato","year":"2013","journal-title":"Expert opinion on pharmacotherapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0020","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13195-021-00831-6","article-title":"Anticancer drugs repurposed for Alzheimer\u2019s disease: A systematic review","volume":"13","author":"Ancidoni","year":"2021","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer's disease: inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"International journal of biological macromolecules"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0035","series-title":"Current and future treatments in Alzheimer's disease. Seminars in neurology","first-page":"227","author":"Atri","year":"2019"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1521-6926(03)00057-4","article-title":"All-trans retinoic acid in acute promyelocytic leukaemia","volume":"16","author":"Avvisati","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.03.064_b9010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/0218492318778485","article-title":"The effect of iodopovidone versus bleomycin in chemical pleurodesis","volume":"26","author":"Bagheri","year":"2018","journal-title":"Asian Cardiovasc Thorac Ann."},{"key":"10.1016\/j.neuroscience.2025.03.064_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42238-022-00119-y","article-title":"Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review","volume":"4","author":"Bahji","year":"2022","journal-title":"Journal of Cannabis Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/jfmpc.jfmpc_578_19","article-title":"Trends in FDA drug approvals over last 2 decades: An observational study","volume":"9","author":"Batta","year":"2020","journal-title":"Journal of family medicine and primary care"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib784","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2165\/00003495-200565090-00003","article-title":"Pharmacological Management of Acute Agitation","volume":"65","author":"Battaglia","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00662-x","article-title":"Repurposed agents in the Alzheimer\u2019s disease drug development pipeline","volume":"12","author":"Bauzon","year":"2020","journal-title":"Alzheimer's research & therapy"},{"issue":"23","key":"10.1016\/j.neuroscience.2025.03.064_bib776","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/14712598.5.4.589","article-title":"Infliximab use in Crohn\u2019s disease","volume":"5","author":"Bewtra","year":"2005","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0065","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/ijms24010884","article-title":"Microglial activation and priming in Alzheimer\u2019s disease: state of the art and future perspectives","volume":"24","author":"Bivona","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/0008-5472.379.65.2","article-title":"Cellular Targets of Gefitinib","volume":"65","author":"Brehmer","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eswa.2019.04.022","article-title":"A practical computerized decision support system for predicting the severity of Alzheimer's disease of an individual","volume":"130","author":"Bucholc","year":"2019","journal-title":"Expert systems with applications"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib787","doi-asserted-by":"crossref","unstructured":"Bukirwa, H., Garner, P., Critchley, J., 2004. Chlorproguanil-dapsone for treating uncomplicated malaria. Cochrane Database Syst Rev. 2004 (4), CD004387. https:\/\/doi.org\/10.1002\/14651858.CD004387.","DOI":"10.1002\/14651858.CD004387"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0085","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1212\/WNL.0000000000001617","article-title":"Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial","volume":"84","author":"Butchart","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.03.064_bib782","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/14740338.2020.1740204","article-title":"Safety update of etanercept treatment for moderate to severe plaque psoriasis","volume":"19","author":"Campanati","year":"2020","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40122-022-00451-4","article-title":"A meta-analysis of randomized controlled trials comparing the efficacy and safety of pregabalin and gabapentin in the treatment of postherpetic neuralgia","volume":"12","author":"Cao","year":"2023","journal-title":"Pain and Therapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.taap.2019.03.016","article-title":"Pharmacology, toxicology and clinical safety of glycopyrrolate","volume":"370","author":"Chabicovsky","year":"2019","journal-title":"Toxicology and applied pharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib795","doi-asserted-by":"crossref","unstructured":"Chanasumon, N., Sriphojanart, T., Suchonwanit, P., 2018. Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis. Drug Des Devel Ther. 12, 365\u2013372. https:\/\/doi.org\/10.2147\/DDDT.S156467.","DOI":"10.2147\/DDDT.S156467"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0110","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.21037\/tlcr-20-467","article-title":"Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell-maintenance factors and inducing apoptosis via the Hedgehog signaling blockade","volume":"9","author":"Chang","year":"2020","journal-title":"Translational Lung Cancer Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-009-8104-z","article-title":"An overview of APP processing enzymes and products","volume":"12","author":"Chow","year":"2010","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40744-015-0016-9","article-title":"Rituximab for rheumatoid arthritis","volume":"2","author":"Cohen","year":"2015","journal-title":"Rheumatology and therapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0125","first-page":"16","article-title":"Emerging evidence for the use of Antidiabetic Drugs, glucagon-like peptide 1 receptor agonists, for the treatment of Alzheimer\u2019s Disease. touchREVIEWS","volume":"19","author":"Colin","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0173-2","article-title":"Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer\u2019s disease","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimer's research & therapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0135","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/eurjpc\/zwab229","article-title":"Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study","volume":"29","author":"d\u2019Erasmo","year":"2022","journal-title":"European journal of preventive cardiology"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.03.064_bib777","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0149-7634(96)00037-1","article-title":"Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies","volume":"21","author":"Danysz","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0140","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.0809158106","article-title":"Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of A\u03b2 oligomers","volume":"106","author":"De Felice","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1567205014666170117141330","article-title":"Poor safety and tolerability hamper reaching a potentially therapeutic dose in the use of thalidomide for Alzheimer\u2019s disease: results from a double-blind, placebo-controlled trial","volume":"14","author":"Decourt","year":"2017","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/OAJCT.S221914","article-title":"MCLENA-1: a phase II clinical trial for the assessment of safety, tolerability, and efficacy of lenalidomide in patients with mild cognitive impairment due to Alzheimer\u2019s disease","author":"Decourt","year":"2020","journal-title":"Open access journal of clinical trials"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0155","doi-asserted-by":"crossref","unstructured":"Deng X. Shang X. Guo K. Zhou L. Wang Y. Wu Y. Liang S. E F. Liu W. Wang Z. Efficacy and safety of antidepressants for smoking cessation: a systematic review and network meta\u2010analysis Addiction Biology 28 8 2023 10.1111\/adb.13303 e13303.","DOI":"10.1111\/adb.13303"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib793","doi-asserted-by":"crossref","unstructured":"Dima, A., Jurcut, C., Chasset, F., Felten, R., Arnaud, L., 2022. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Ther Adv Musculoskelet Dis. 14, 1759720X211073001. https:\/\/doi.org\/10.1177\/1759720X211073001.","DOI":"10.1177\/1759720X211073001"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105314","article-title":"The impact of the microbiota-gut-brain axis on Alzheimer\u2019s disease pathophysiology","volume":"164","author":"Doifode","year":"2021","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1210951","article-title":"A phase 3 trial of semagacestat for treatment of Alzheimer's disease","volume":"369","author":"Doody","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-023-01169-x","article-title":"Masitinib for mild-to-moderate Alzheimer\u2019s disease: results from a randomized, placebo-controlled, phase 3, clinical trial","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimer's Research & Therapy"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.03.064_bib780","first-page":"850","article-title":"Efficacy and safety of fixed-dose\/sublingual apomorphine in men with erectile dysfunction","volume":"57","author":"Dula","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0180","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamainternmed.2021.4607","article-title":"Approval of aducanumab for Alzheimer disease\u2014the FDA\u2019s perspective","volume":"181","author":"Dunn","year":"2021","journal-title":"JAMA internal medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0185","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/WNF.0b013e3181e71166","article-title":"Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease","volume":"33","author":"Dusek","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0190","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib816","doi-asserted-by":"crossref","unstructured":"Endres, K., Fahrenholz, F., Lotz, J., Hiemke, C., Teipel, S., Lieb, K., T\u00fcscher, O., Fellgiebel, A., 2014. Increased CSF APPs-\u03b1 levels in patients with Alzheimer disease treated with acitretin. Neurology. 83 (21), 1930\u20131935. https:\/\/doi.org\/10.1212\/WNL.0000000000001017.","DOI":"10.1212\/WNL.0000000000001017"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.03.064_bib810","doi-asserted-by":"crossref","first-page":"85","DOI":"10.47717\/turkjsurg.2025.6687","article-title":"Trastuzumab significantly improves survival in resectable HER-2 positive gastric cancer: A retrospective study","volume":"41","author":"Erdem","year":"2025","journal-title":"Turk J Surg"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0195","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.4088\/JCP.v59n0306","article-title":"A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety","volume":"59","author":"Fawcett","year":"1998","journal-title":"The Journal of clinical psychiatry"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0200","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/WNL.0b013e3181d6476a","article-title":"Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe","volume":"74","author":"Feldman","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bmcl.2018.11.034","article-title":"New approaches for the treatment of Alzheimer\u2019s disease","volume":"29","author":"Fish","year":"2019","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0210","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc08-0283","article-title":"Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy","volume":"31","author":"Fonseca","year":"2008","journal-title":"Diabetes care"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2019.00099","article-title":"Subregional Density of Neurons, Neurofibrillary Tangles and Amyloid Plaques in the Hippocampus of Patients With Alzheimer\u2019s Disease","volume":"13","author":"Furcila","year":"2019","journal-title":"Frontiers in Neuroanatomy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0220","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic acids research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0225","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrd2030","article-title":"Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond","volume":"5","author":"Ghofrani","year":"2006","journal-title":"Nature reviews Drug discovery"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1033272","article-title":"Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease","volume":"9","author":"Gibson","year":"2022","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0235","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biopha.2018.11.127","article-title":"An update on Drug Repurposing: Re-written saga of the drug's fate","volume":"110","author":"Gns","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0240","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199210223271701","article-title":"The effect of finasteride in men with benign prostatic hyperplasia","volume":"327","author":"Gormley","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib822","doi-asserted-by":"crossref","unstructured":"Green, R.C., Schneider, L.S., Amato, D.A., Beelen, A.P., Wilcock, G., Swabb, E.A., Zavitz, K.H., 2009. Tarenflurbil Phase 3 Study Group. Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA 302 (23), 2557\u20132564. https:\/\/doi.org\/10.1001\/jama.2009.","DOI":"10.1001\/jama.2009.1866"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0245","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019832226","article-title":"Drug repositioning in pulmonary arterial hypertension: challenges and opportunities","volume":"9","author":"Grinnan","year":"2019","journal-title":"Pulmonary Circulation"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0250","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/00003643-200011000-00004","article-title":"Lidocaine inhalation for local anaesthesia and attenuation of bronchial hyper-reactivity with least airway irritation. Effect of three different dose regimens","volume":"17","author":"Groeben","year":"2000","journal-title":"European journal of anaesthesiology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0255","doi-asserted-by":"crossref","unstructured":"Group A.R. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial Neurology 68 2007 1800 1808.","DOI":"10.1212\/01.wnl.0000260269.93245.d2"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0260","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/archneur.2008.65.7.nct70006","article-title":"Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib","volume":"65","author":"Group","year":"2008","journal-title":"Archives of neurology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0265","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.tips.2013.06.005","article-title":"Cancer drug discovery by repurposing: teaching new tricks to old dogs","volume":"34","author":"Gupta","year":"2013","journal-title":"Trends in pharmacological sciences"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib820","doi-asserted-by":"crossref","unstructured":"Ha, J., Choi, D.W., Kim, K.J., Kim, K.Y., Nam, C.M., Kim, E., 2023. Pioglitazone Use and Reduced Risk of Dementia in Patients With Diabetes Mellitus With a History of Ischemic Stroke. Neurology. 100 (17), e1799\u2013e1811. https:\/\/doi.org\/10.1212\/WNL.0000000000207069. Epub 2023 Feb 15. PMID: 36792375; PMCID: PMC10136019.","DOI":"10.1212\/WNL.0000000000207069"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.03.064_bib821","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156720511796391935","article-title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer\u2019s disease: two phase 3 studies","volume":"8","author":"Harrington","year":"2011","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.03.064_bib796","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","article-title":"Repurposing metformin for the prevention of cancer and cancer recurrence","volume":"60","author":"Heckman-Stoddard","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0275","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.drudis.2011.06.010","article-title":"Serological biochemical markers of surrogate efficacy and safety as a novel approach to drug repositioning","volume":"16","author":"Henriksen","year":"2011","journal-title":"Drug discovery today"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00770","article-title":"Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery","volume":"11","author":"Hinkson","year":"2020","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0285","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/wsbm.1337","article-title":"In silico methods for drug repurposing and pharmacology","volume":"8","author":"Hodos","year":"2016","journal-title":"WIREs Systems Biology and Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0290","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer\u2019s disease","volume":"378","author":"Honig","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib785","doi-asserted-by":"crossref","unstructured":"Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Belli, R., Maestroni, S., Trinchero, R., Spodick, D.H., Adler, Y., 2011. CORP (COlchicine for Recurrent Pericarditis) Investigators. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 155 (7), 409\u2013414. https:\/\/doi.org\/10.7326\/0003-4819-155-7-201110040-00359.","DOI":"10.7326\/0003-4819-155-7-201110040-00359"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.03.064_bib797","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","article-title":"Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study","volume":"98","author":"Ineda","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.neuroscience.2025.03.064_b6000","doi-asserted-by":"crossref","unstructured":"A.A. Ishola, 2023. Perspective Chapter: Aspirin \u2013 The Wonder Drug. https:\/\/doi.org\/10.5772\/intechopen.111571.","DOI":"10.5772\/intechopen.111571"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib806","doi-asserted-by":"crossref","unstructured":"Jiang, W., Hu, J.W., He, X.R., Jin, W.L., He, X.Y., 2021. Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res. 40 (1), 241. https:\/\/doi.org\/10.1186\/s13046-021-02041-2.","DOI":"10.1186\/s13046-021-02041-2"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib800","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10787-024-01608-7","article-title":"Drugs repurposing in the experimental models of Alzheimer\u2019s disease","volume":"33","author":"Joodi","year":"2025","journal-title":"Inflammopharmacol"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0305","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0310","article-title":"Clinical utility of mifepristone: apprising the expanding horizons","volume":"14","author":"Karena","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib828","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/ph17010140","article-title":"Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Crossover, Placebo-Controlled Pilot Study","volume":"17","author":"Kokoszka","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.03.064_bib825","first-page":"41","article-title":"Diagnosis and management of Bartter syndrome","volume":"32","author":"Konrad","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0315","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13195-024-01573-x","article-title":"Inflammatory proteins associated with Alzheimer\u2019s disease reduced by a GLP1 receptor agonist: A post hoc analysis of the EXSCEL randomized placebo controlled trial","volume":"16","author":"Koychev","year":"2024","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0320","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1186\/s12913-022-08272-z","article-title":"Drug repurposing: a systematic review on root causes, barriers and facilitators","volume":"22","author":"Krishnamurthy","year":"2022","journal-title":"BMC Health Services Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0330","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on Alzheimer's disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacological Reports"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib815","doi-asserted-by":"crossref","unstructured":"Kumar, R., Harilal, S., Gupta, S.V., Jose, J., Thomas Parambi, D.G., Uddin, M.S., Shah, M.A., Mathew, B., 2019. Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work. Eur J Med Chem. 182, 111602. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111602.","DOI":"10.1016\/j.ejmech.2019.111602"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.03.064_bib786","first-page":"CD003153","article-title":"D-cycloserine for Alzheimer\u2019s disease","volume":"2002","author":"Laake","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.03.064_b9005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nephro.2012.08.002","article-title":"Indications actuelles de l'azathioprine en n\u00e9phrologie [Current indications of azathioprine in nephrology]","volume":"9","author":"Ladri\u00e8re","year":"2013","journal-title":"Nephrol. Ther."},{"key":"10.1016\/j.neuroscience.2025.03.064_b0340","article-title":"Intepirdine as adjunctive therapy to donepezil for mild\u2010to\u2010moderate Alzheimer's disease: a randomized, placebo\u2010controlled, phase 3 clinical trial (MINDSET)","volume":"7","author":"Lang","year":"2021","journal-title":"Alzheimer's & dementia: translational research & clinical interventions"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib819","doi-asserted-by":"crossref","unstructured":"Lawlor, B., Segurado, R., Kennelly, S., Olde Rikkert, M.G.M., Howard, R., Pasquier, F., B\u00f6rjesson-Hanson, A., Tsolaki, M., Lucca, U., Molloy, D.W., Coen, R., Riepe, M.W., K\u00e1lm\u00e1n, J., Kenny, R.A., Cregg, F., O'Dwyer, S., Walsh, C., Adams, J., Banzi, R., Breuilh, L., Daly, L., Hendrix, S., Aisen, P., Gaynor, S., Sheikhi, A., Taekema, D.G., Verhey, F.R., Nemni, R., Nobili, F., Franceschi, M., Frisoni, G., Zanetti, O., Konsta, A., Anastasios, O., Nenopoulou, S., Tsolaki-Tagaraki, F., Pakaski, M., Dereeper, O., de la Sayette, V., S\u00e9n\u00e9chal, O., Lavenu, I., Devendeville, A., Calais, G., Crawford, F., Mullan, M., NILVAD Study Group, 2018. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Med. 15(9), e1002660.","DOI":"10.1371\/journal.pmed.1002660"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0345","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.maturitas.2008.04.009","article-title":"Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women","volume":"60","author":"Lee","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0350","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/bib\/bbv020","article-title":"A survey of current trends in computational drug repositioning","volume":"17","author":"Li","year":"2016","journal-title":"Briefings in bioinformatics"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0355","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1517\/14656566.5.4.933","article-title":"Finasteride in the treatment of alopecia","volume":"5","author":"Libecco","year":"2004","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib794","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.3390\/ijms24044154","article-title":"Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer","volume":"24","author":"Louren\u00e7o","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0360","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41386-021-01191-3","article-title":"The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer\u2019s disease: a randomized, triple-blind, placebo-controlled trial","volume":"47","author":"Louzada","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0365","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2174\/1568026616666160530181149","article-title":"Molecular Docking for Identification of Potential Targets for Drug Repurposing","volume":"16","author":"Luo","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0370","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(02)01423-1","article-title":"The discovery and status of sibutramine as an anti-obesity drug","volume":"440","author":"Luque","year":"2002","journal-title":"European journal of pharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00298","article-title":"On the Integration of In Silico Drug Design Methods for Drug Repurposing","volume":"8","author":"March-Vila","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0380","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1517\/14656566.3.6.755","article-title":"Paclitaxel in cancer therapy","volume":"3","author":"Markman","year":"2002","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.03.064_bib803","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/pde.12022","article-title":"Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers","volume":"30","author":"Martin","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0385","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/a-1658-3077","article-title":"Sunitinib-induced hypothyroidism and survival in pancreatic neuroendocrine tumors","volume":"53","author":"Mathew","year":"2021","journal-title":"Hormone and Metabolic Research"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.03.064_bib778","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.37.4.589","article-title":"Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood","volume":"37","author":"Max","year":"1987","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.03.064_bib817","first-page":"CD003160","article-title":"Statins for the prevention of dementia","volume":"2016","author":"McGuinness","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0390","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.4103\/1673-5374.193234","article-title":"Neurofibrillary tangles in Alzheimer's disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics","volume":"11","author":"Metaxas","year":"2016","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0395","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer\u2019s Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0400","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamaneurol.2021.3356","article-title":"Effect of methylphenidate on apathy in patients with Alzheimer disease: the ADMET 2 randomized clinical trial","volume":"78","author":"Mintzer","year":"2021","journal-title":"JAMA neurology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0405","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1037\/1064-1297.10.3.213","article-title":"Clinical uses of naltrexone: a review of the evidence","volume":"10","author":"Modesto-Lowe","year":"2002","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0410","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.trci.2017.10.005","article-title":"Drug discovery and development: Role of basic biological research","volume":"3","author":"Mohs","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib792","doi-asserted-by":"crossref","unstructured":"Mucke, H.A., 2015. The case of galantamine: repurposing and late blooming of a cholinergic drug. Future Sci OA. 1 (4), FSO73. https:\/\/doi.org\/10.4155\/fso.15.73.","DOI":"10.4155\/fso.15.73"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0415","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3233\/JAD-215065","article-title":"A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease","volume":"83","author":"Mukhopadhyay","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0420","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1017\/S1461145713000771","article-title":"Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release","volume":"16","author":"Nagayasu","year":"2013","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0425","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pbb.2013.04.005","article-title":"Potential therapeutic uses of mecamylamine and its stereoisomers","volume":"108","author":"Nickell","year":"2013","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0435","series-title":"Drugs in tuberculosis and leprosy","author":"Onakpoya","year":"2021"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0440","first-page":"15","article-title":"Milnacipran for the management of fibromyalgia syndrome","author":"Ormseth","year":"2010","journal-title":"Journal of pain research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0445","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/WCO.0000000000000460","article-title":"Imaging plus X: multimodal models of neurodegenerative disease","volume":"30","author":"Oxtoby","year":"2017","journal-title":"Current opinion in neurology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0450","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0022-3859.81870","article-title":"Drug repositioning: re-investigating existing drugs for new therapeutic indications","volume":"57","author":"Padhy","year":"2011","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0455","doi-asserted-by":"crossref","unstructured":"Parisi, D., Adasme, M., Sveshnikova, A., Moreau, Y. & Schroeder, M. 2019. Drug repositoning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs.","DOI":"10.1101\/715094"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0460","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMoa021007","article-title":"A paclitaxel-eluting stent for the prevention of coronary restenosis","volume":"348","author":"Park","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0465","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/IJNRD.S4191","article-title":"The use of everolimus in renal-transplant patients","author":"Pascual","year":"2009","journal-title":"International Journal of Nephrology and Renovascular Disease"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0470","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s13346-019-00650-1","article-title":"Recent advances in cyclosporine drug delivery: Challenges and opportunities","volume":"9","author":"Patel","year":"2019","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.esxm.2020.100296","article-title":"Safety and effectiveness of dapoxetine on demand in Chinese men with premature ejaculation: Results of a multicenter, prospective, open-label phase IV study","volume":"9","author":"Peng","year":"2021","journal-title":"Sexual Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0480","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12886-022-02621-6","article-title":"A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances","volume":"22","author":"Pepose","year":"2022","journal-title":"BMC ophthalmology"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.03.064_bib812","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2165\/00003495-200464110-00004","article-title":"Zoledronic acid: a review of its use in patients with advanced cancer","volume":"64","author":"Perry","year":"2004","journal-title":"Drugs"},{"issue":"13","key":"10.1016\/j.neuroscience.2025.03.064_bib798","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.3390\/cancers13133193","article-title":"Repurposing of antimicrobial agents for cancer therapy: what do we know?","volume":"13","author":"Pfab","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0485","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fonc.2018.00163","article-title":"Past, present, and future of rituximab\u2014the world\u2019s first oncology monoclonal antibody therapy","volume":"8","author":"Pierpont","year":"2018","journal-title":"Frontiers in oncology"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib788","unstructured":"Pour-Reza-Gholi, F., Nasrollahi, A., Firouzan, A., Nasli Esfahani, E., Farrokhi, F., 2007. Low-dose doxepin for treatment of pruritus in patients on hemodialysis. Iran J Kidney Dis. 1 (1), 34\u201337. PMID: 19357442."},{"key":"10.1016\/j.neuroscience.2025.03.064_b0495","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.17845.3","article-title":"A rational approach to drug repositioning in \u03b2-thalassemia: Induction of fetal hemoglobin by established drugs","volume":"7","author":"Prosdocimi","year":"2022","journal-title":"Wellcome Open Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0505","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib826","doi-asserted-by":"crossref","unstructured":"Rabbie, R., Derry, S., Moore, R.A., 2013. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013 (4), CD008039. https:\/\/doi.org\/10.1002\/14651858.","DOI":"10.1002\/14651858.CD008039.pub3"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0510","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020\u20132060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib790","doi-asserted-by":"crossref","unstructured":"Rajasekaran, S., Bupp, C.P., Leimanis-Laurens, M., Shukla, A., Russell, C., Junewick, J., Gleason, E., VanSickle, E.A., Edgerly, Y., Wittmann, B.M., Prokop, J.W., Bachmann, A.S., 2021. Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease. Elife. 10, e67097. https:\/\/doi.org\/10.7554\/eLife.67097.","DOI":"10.7554\/eLife.67097"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0515","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.2174\/1381612823666170601105439","article-title":"Methotrexate in the treatment of psoriasis and rheumatoid arthritis: mechanistic insights, current issues and novel delivery approaches","volume":"23","author":"Rajitha","year":"2017","journal-title":"Current pharmaceutical design"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0520","doi-asserted-by":"crossref","DOI":"10.1002\/alz.085738","article-title":"Escitalopram for Agitation in Alzheimer\u2019s Dementia","volume":"20","author":"Rajji","year":"2024","journal-title":"Alzheimer's & Dementia"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0525","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: A review of efficacy and safety","volume":"84","author":"Randolph","year":"2021","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0530","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","article-title":"Hippocampus and its involvement in Alzheimer's disease: a review","volume":"12","author":"Rao","year":"2022","journal-title":"3 Biotech"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.03.064_bib824","first-page":"465","article-title":"Diagnosis and treatment of PMDD","volume":"169","author":"Rapkin","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0535","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/17425255.2016.1184649","article-title":"Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemia","volume":"12","author":"Ravegnini","year":"2016","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0540","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Rofecoxib: no effect on Alzheimer\u2019s disease in a 1-year, randomized, blinded, controlled study","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0545","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1212\/WNL.0000000000003904","article-title":"A phase 3 trial of IV immunoglobulin for Alzheimer disease","volume":"88","author":"Relkin","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib805","doi-asserted-by":"crossref","first-page":"10171","DOI":"10.1038\/s41598-021-89562-0","article-title":"Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience","volume":"11","author":"Revilla-L\u00f3pez","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0550","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/medicina55090554","article-title":"Efficacy of low-dose paroxetine for the treatment of hot flushes in surgical and physiological postmenopausal women: systematic review and meta-analysis of randomized trials","volume":"55","author":"Riemma","year":"2019","journal-title":"Medicina"},{"issue":"12","key":"10.1016\/j.neuroscience.2025.03.064_bib818","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0555","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.14642","article-title":"Minocycline in neurodegenerative and psychiatric diseases: an update","volume":"28","author":"Romero-Miguel","year":"2021","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0565","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ibneur.2024.07.002","article-title":"Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer\u2019s patients: A double-blind placebo-controlled randomized clinical trial","volume":"17","author":"Rustamzadeh","year":"2024","journal-title":"IBRO neuroscience reports"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0570","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.trci.2016.10.001","article-title":"A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol","volume":"2","author":"Saito","year":"2016","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0575","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","article-title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer\u2019s disease","volume":"27","author":"Salloway","year":"2021","journal-title":"Nature medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0580","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.03.064_bib783","first-page":"1234","article-title":"Budesonide MMX for mild-to-moderate ulcerative colitis: A pooled analysis","volume":"21","author":"Sandborn","year":"2023","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106379","article-title":"A journey of celecoxib from pain to cancer","volume":"147","author":"Saxena","year":"2020","journal-title":"Prostaglandins & other lipid mediators"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib789","doi-asserted-by":"crossref","unstructured":"Scholz, B.A., Hammonds, C.L., 2009. Boomershine CS. Duloxetine for the management of fibromyalgia syndrome. J Pain Res. 2, 99\u2013108.","DOI":"10.2147\/JPR.S4462"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0595","doi-asserted-by":"crossref","first-page":"17393","DOI":"10.1021\/acsomega.9b02160","article-title":"Fingerprinting CANDO: Increased Accuracy with Structure- and Ligand-Based Shotgun Drug Repurposing","volume":"4","author":"Schuler","year":"2019","journal-title":"ACS omega"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0600","series-title":"Sunitinib","author":"Shan","year":"2012"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0610","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ana.10292","article-title":"Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: a 26\u2010week randomized, placebo\u2010controlled, double\u2010blind trial","volume":"52","author":"Simons","year":"2002","journal-title":"Annals of neurology"},{"issue":"21","key":"10.1016\/j.neuroscience.2025.03.064_bib807","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0615","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.3390\/cancers14102424","article-title":"HER-2-targeted nanoparticles for breast cancer diagnosis and treatment","volume":"14","author":"Sitia","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0620","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000069989","article-title":"Treatment with simvastatin in patients with Alzheimer\u2019s disease lowers both \u03b1-and \u03b2-cleaved amyloid precursor protein","volume":"16","author":"Sj\u00f6gren","year":"2003","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0625","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1345\/aph.1R573","article-title":"Evidence for therapeutic uses of nebulized lidocaine in the treatment of intractable cough and asthma","volume":"47","author":"Slaton","year":"2013","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0630","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1756285613481257","article-title":"Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity","volume":"6","author":"Sommer","year":"2013","journal-title":"Therapeutic advances in neurological disorders"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0635","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1567205054367900","article-title":"Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD","volume":"2","author":"Sparks","year":"2005","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0640","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0377-1237(17)30452-5","article-title":"SILDENAFIL-ORAL MEDICATION FOR ERECTILE DYSFUNCTION-A REVIEW","volume":"55","author":"Srinath","year":"1999","journal-title":"Medical journal, Armed Forces India"},{"issue":"23","key":"10.1016\/j.neuroscience.2025.03.064_b9020","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJM199506083322301","article-title":"Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine\/Premenstrual Dysphoria Collaborative Study Group","volume":"332","author":"Steiner","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuroscience.2025.03.064_b0645","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0650","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00221","article-title":"\u03b2-Amyloid: The Key Peptide in the Pathogenesis of Alzheimer\u2019s Disease","volume":"6","author":"Sun","year":"2015","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib827","doi-asserted-by":"crossref","unstructured":"Sundar, S., Jha, T.K., Thakur, C.P., Engel, J., Sindermann, H., Fischer, C., Junge, K., Bryceson, A., Berman, J., 2002. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med. 347 (22), 1739\u20131746. https:\/\/doi.org\/10.1056\/NEJMoa021556.","DOI":"10.1056\/NEJMoa021556"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0655","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"Sundar","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0660","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/cts.12577","article-title":"The current status of drug discovery and development as originated in United States academia: the influence of industrial and academic collaboration on drug discovery and development","volume":"11","author":"Takebe","year":"2018","journal-title":"Clinical and translational science"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0665","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1212\/WNL.0000000000200771","article-title":"Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study","volume":"99","author":"Tang","year":"2022","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neuroscience.2025.03.064_bib823","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archgenpsychiatry.2011.72","article-title":"Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease","volume":"68","author":"Tariot","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0670","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.28982\/josam.1002126","article-title":"Comparison of two drospirenone-containing oral contraceptives for their effect on the ovary, menstrual cycle, acne, and side-effect profile: 20 \u00b5g ethinylestradiol\/3 mg drospirenone (24\/4) versus 30 \u00b5g ethinylestradiol\/3 mg drospirenone (21\/7)","volume":"5","author":"Ta\u015fk\u00f6m\u00fcr","year":"2021","journal-title":"Journal of Surgery and Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0680","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nbd.2008.04.011","article-title":"Endogenous secreted amyloid precursor protein-\u03b1 regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory","volume":"31","author":"Taylor","year":"2008","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0685","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/receptors4010002","article-title":"Exploring the Role of GLP-1 Receptor Agonists in Alzheimer\u2019s Disease: A Review of Preclinical and Clinical Evidence","volume":"4","author":"Teixeira","year":"2025","journal-title":"Receptors"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0690","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1096\/fj.08-121392","article-title":"Up\u2010regulation of the \u03b1\u2010secretase ADAM10 by retinoic acid receptors and acitretin","volume":"23","author":"Tippmann","year":"2009","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0695","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0700","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3390\/ijms25052727","article-title":"The single toxin origin of Alzheimer\u2019s disease and other neurodegenerative disorders enables targeted approach to treatment and prevention","volume":"25","author":"Tolar","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.neuroscience.2025.03.064_bib802","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/1758834016644155","article-title":"Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes","volume":"8","author":"Tomasini","year":"2016","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0705","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cns.12802","article-title":"Candesartan ameliorates brain inflammation associated with Alzheimer's disease","volume":"24","author":"Torika","year":"2018","journal-title":"CNS neuroscience & therapeutics"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0710","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1517\/14796694.1.1.7","article-title":"Role of gemcitabine in cancer therapy","volume":"1","author":"Toschi","year":"2005","journal-title":"Future oncology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0720","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.25775","article-title":"Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer's disease","volume":"88","author":"Turner","year":"2020","journal-title":"Annals of neurology"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0730","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fncel.2018.00226","article-title":"Repositioning microtubule stabilizing drugs for brain disorders","volume":"12","author":"Varidaki","year":"2018","journal-title":"Frontiers in cellular neuroscience"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0735","doi-asserted-by":"crossref","unstructured":"Vellas B. Sol O. J. Snyder P. Ousset P.-J. Haddad R. Maurin M. Lemarie J.-C. Desire L. P. Pando M. EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study Current Alzheimer Research 8 2 2011 203 212 10.2174\/156720511795256053.","DOI":"10.2174\/156720511795256053"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0740","first-page":"3078","article-title":"Repurposing drugs for management of Alzheimer disease","volume":"12","author":"Venkatachalam","year":"2019","journal-title":"Res J Pharm Technol"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116884","article-title":"Estimating the therapeutic potential of NSAIDs and linoleic acid-isomers supplementation against neuroinflammation","volume":"177","author":"Vieira","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0750","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gkw1118","article-title":"Pubchem bioassay: 2017 update","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic acids research"},{"issue":"20","key":"10.1016\/j.neuroscience.2025.03.064_bib813","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJM199105163242002","article-title":"Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)","volume":"324","author":"Warrell","year":"1991","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.03.064_b9015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/105500490290087901","article-title":"The use of intravenous buprenorphine for the treatment of opioid withdrawal in medically ill hospitalized patients","volume":"11","author":"Welsh","year":"2002","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuroscience.2025.03.064_b0755","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-142874","article-title":"Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease","volume":"44","author":"Wischik","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0760","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic acids research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0765","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.862369","article-title":"Amyloid-related imaging abnormalities with anti-amyloid antibodies for the treatment of dementia due to Alzheimer's disease","volume":"13","author":"Withington","year":"2022","journal-title":"Frontiers in Neurology"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.03.064_bib814","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/cancers12020441","article-title":"Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?","volume":"12","author":"Wojcicki","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.neuroscience.2025.03.064_bib779","article-title":"Clinical practice guideline for ADHD in children","volume":"144","author":"Wolraich","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib809","doi-asserted-by":"crossref","unstructured":"Wong, C.H., Siah, K.W., Lo, A.W., 2019. Estimation of clinical trial success rates and related parameters. Biostatistics 20 (2), 273\u2013286. https:\/\/doi.org\/10.1093\/biostatistics\/kxx069.","DOI":"10.1093\/biostatistics\/kxx069"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0770","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/ijbs.24612","article-title":"Review of drug repositioning approaches and resources","volume":"14","author":"Xue","year":"2018","journal-title":"International journal of biological sciences"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0775","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733364","article-title":"Interferon and hepatitis B: current and future perspectives","volume":"12","author":"Ye","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.03.064_bib808","first-page":"297","article-title":"Mycophenolate mofetil in the treatment of lupus nephritis","volume":"2","author":"Yong","year":"2008","journal-title":"Biologics"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib804","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib801","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Zhao, W., Wang, H., Zhao, Y., Bu, H., Takahashi, H., 2022. Pioglitazone on nonalcoholic steatohepatitis: A systematic review and meta-analysis of 15 RCTs. Medicine (Baltimore). 101 (46), e31508. https:\/\/doi.org\/10.1097\/MD.0000000000031508.","DOI":"10.1097\/MD.0000000000031508"},{"key":"10.1016\/j.neuroscience.2025.03.064_bib811","doi-asserted-by":"crossref","unstructured":"Zouboulis, C.C., 2009. Zileuton, a new efficient and safe systemic anti-acne drug. Dermatoendocrinol. 1 (3), 188\u2013192. https:\/\/doi.org\/10.4161\/derm.1.3.8368.","DOI":"10.4161\/derm.1.3.8368"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0005","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s11094-015-1321-x","article-title":"Synthesis and evaluation of analgesic and anti-inflammatory properties of novel ibuprofen analogs","volume":"49","author":"Ahmadi","year":"2015","journal-title":"Pharmaceutical Chemistry Journal"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0080","doi-asserted-by":"crossref","first-page":"e192810","DOI":"10.1001\/jamanetworkopen.2019.2810","article-title":"Assessment of outcomes of inpatient or clinic-based vs home-based rehabilitation after total knee arthroplasty: a systematic review and meta-analysis","volume":"2","author":"Buhagiar","year":"2019","journal-title":"JAMA network open"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0100","doi-asserted-by":"crossref","first-page":"927","DOI":"10.7326\/0003-4819-91-6-927_2","article-title":"Phentolamine for primary pulmonary hypertension","volume":"91","author":"Cha","year":"1979","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0270","first-page":"300","article-title":"Hypertension in the native rural population of Assam","volume":"17","author":"Hazarika","year":"2004","journal-title":"Natl Med J India"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0295","doi-asserted-by":"crossref","first-page":"60","DOI":"10.21477\/ijapsr.5.4.2","article-title":"Drug Repurposing: A Paradigm Shift in Drug Discovery","volume":"5","author":"Jayaram","year":"2020","journal-title":"INTERNATIONAL JOURNAL OF APPLIED PHARMACEUTICAL SCIENCES AND RESEARCH"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0300","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2471\/BLT.16.181636","article-title":"Stroke: a global response is needed","volume":"94","author":"Johnson","year":"2016","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0325","unstructured":"Kuchler, H. (2019). Pharma groups combine to promote drug discovery with AI. Financial Times June, 4, 2019."},{"key":"10.1016\/j.neuroscience.2025.03.064_b0430","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/15289168.2019.1583053","article-title":"Identity narrative and its role in biological survival: Implications for child and adolescent psychotherapy","volume":"18","author":"Novac","year":"2019","journal-title":"Journal of Infant, Child, and Adolescent Psychotherapy"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0490","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/1567205016666190321163438","article-title":"Therapeutic strategies targeting amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"16","author":"Pinheiro","year":"2019","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0560","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1513\/AnnalsATS.201702-101OC","article-title":"Discovering pediatric asthma phenotypes on the basis of response to controller medication using machine learning","volume":"15","author":"Ross","year":"2018","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0590","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0605","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d741","article-title":"Old drugs, new tricks","volume":"342","author":"Shaughnessy","year":"2011","journal-title":"Bmj"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0675","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/j.drudis.2020.09.025","article-title":"Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's disease","volume":"25","author":"Tatiparti","year":"2020","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0715","doi-asserted-by":"crossref","unstructured":"S. Tsang W. Auyeung K., Bian, Z. & Ko, J. Pathogenesis, experimental models and contemporary pharmacotherapy of irritable bowel syndrome: story about the brain-gut axis Current Neuropharmacology 14 2016 842 856.","DOI":"10.2174\/1570159X14666160324144154"},{"key":"10.1016\/j.neuroscience.2025.03.064_b0725","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.msec.2017.07.040","article-title":"Development and characterization of miltefosine-loaded polymeric micelles for cancer treatment","volume":"81","author":"Valenzuela-Oses","year":"2017","journal-title":"Materials Science and Engineering: C"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225002660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225002660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T12:25:14Z","timestamp":1747398314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225002660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":208,"alternative-id":["S0306452225002660"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.03.064","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review: From old drugs to new solutions: The role of repositioning in alzheimer\u2019s disease treatment","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.03.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}